Educational Qualifications

B.Pharm, M. Pharm, PhD, Postdoc (Portugal), MBA

Area of Specialization / Research

Nanomedicine &Nanotheranostics, Bioconjugates, Stem Cell Research for Tissue Engineering, Drug Discovery & Repurposing, 3D Printing for Personalized & Precision Medicine, Targeted Phytochemicals Delivery

Notable Publications

  1. 1.

    Poonia N, Kaur Narang J, Lather V, Beg S, Sharma T, Singh B, Pandita D . Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: Systematic development, characterization and pharmacokinetic evaluation. Colloids and Surfaces B: Biointerfaces, 2019, 181, 756-766.

    2019
  2. 2.

    Girdhar S, Girdhar A, Lather V, Pandita D. Aegle marmelos leaf extract ameliorates the cognitive impairment and oxidative stress induced by intracerebroventricular streptozotocin in male rats. Life Sciences, 2019, 221, 196–203.

    2019
  3. 3.

    Chauhan A., Grewal A. S., Pandita D ., Lather V. Novel Cinnamic Acid Derivatives as Potential PPARδ Agonists for Metabolic Syndrome: Design, Synthesis, Evaluation and Docking Studies. Current Drug Discovery Technologies, 2019, Accepted.

    2019
  4. 4.

    Poonia N., Lather V., Pandita D., Mesoporous silica nanoparticles: a smart nanosystem for management of breast cancer. Drug Discovery Today, 2018, 23(2), 315-332.

    2018
  5. 5.

    Girdhar S, Girdhar A, Lather V, Pandita D. Biochanin A: A phytoestrogen with therapeutic potential. Trends in Food Science & Technology , 2018, 79, 55-66.

    2018
  6. 6.

    Singh H, Singla YP, Narang RS, Pandita D, Singh S, Narang JK, Frovatriptan loaded hydroxy propyl methyl cellulose/treated chitosan based T composite fast dissolving sublingual films for management of migraine. Journal of Drug Delivery Science and Technology, 2018, 47, 230-9.

    2018
  7. 7.

    Pandita D., Editorial- Global Regulatory Overview of Nanopharmaceuticals and Nanocosmetics, Part-I Applied Clinical Research, Clinical Trials and Regulatory Affairs, 2018, Vol. 5, Issue 2

    2018
  8. 8.

    Pandita D., Editorial- Global Regulatory Overview of Nanopharmaceuticals and Nanocosmetics, Part-II Applied Clinical Research, Clinical Trials and Regulatory Affairs, 2018, Vol. 5, Issue 3

    2018
  9. 9.

    Charaya N., Pandita D., Grewal A.S., Lather V., Design, synthesis and biological evaluation of novel thiazol-2-yl benzamide derivatives as glucokinase activators Computational Biology and Chemistry, 2018, 73, 221-229.

    2018
  10. 10.

    Sharma H., Lather V., Grewal A.S., Pandita D., Synthesis, Anti-inflammatory Activity and Docking Studies of Some Newer 1,3- Thiazolidine-2,4-dione Derivatives as Dual Inhibitors of PDE4 and PDE7 Current Computer Aided Drug Design, 2018, Oct 3.

    2018
  11. 11.

    Kumar A., Grewal A.S., Singh V., Narang R., Pandita D., Lather V., Synthesis, Antimicrobial Activity and QSAR Studies of Some New Sparfloxacin Derivatives Pharmaceutical Chemistry Journal, 2018, 52, 444–454.

    2018
  12. 12.

    Grewal A.S., Lather V., Sharma N., Singh S., Narang R. S., Narang J.K., Pandita D. Recent Updates on Nanomedicine Based Products: Current Scenario and Future Opportunities Applied Clinical Research, Clinical Trials and Regulatory Affairs, 2018, 5, 132-144.

    2018
  13. 13.

    Narang J.K., Narang R.S., Pandita D., Lather V., Dogra A. Nano-Oncologicals: Regulatory Aspects and Safety Issues Applied Clinical Research, Clinical Trials and Regulatory Affairs, 2018, 5, 122 – 131.

    2018
  14. 14.

    Grewal A. S., Sharma K., Singh S., Singh V., Pandita D., Lather V. Design, Synthesis and Antidiabetic Activity of Novel Sulfamoyl Benzamide Derivatives as Glucokinase Activators Journal of Pharmaceutical Technology Research and Management, 2018, 6, 115- 124.

    2018
  15. 15.

    Singh P., Grewal A.S., Pandita D., Lather V. Synthesis and evaluation of a series of caffeic acid derivatives as anticancer agents. Future Journal of Pharmaceutical Sciences, 2017, accepted.

    2017
  16. 16.

    Lather V., Saini V., Pandita D.,Polymeric micelles of modified chitosan block copolymer as nanocarrier for delivery of paclitaxel Current Nanomedicine, 2017, accepted.

    2017
  17. 17.

    Pandita D., Kumari N., Lather V., A selfnanoemulsifying drug delivery system for poorly water soluble tolbutamide: development, optimization and pharmacodynamic studies Pharmaceutical Nanotechnology, 2017, accepted.

    2017
  18. 18.

    Hooda R., Pandita D., Kumari P., Lather V.; Regulatory and quality aspects of herbal drugs Applied Clinical Research, Clinical Trials and Regulatory Affairs, 2017, 4(2), 107-113

    2017
  19. 19.

    Girdhar S., Girdhar A., Lather V. , Pandita D.; Novel therapeutic targets for Human African Trypanosomiasis Current Treatment Options in Infectious Diseases, 2017, 9(2), 200-209.

    2017
  20. 20.

    Grewal A. S., Lather V., Pandita D., Bhayana G., Synthesis, docking and biological evaluation of phenylacetic acid and trifluoromethylphenyl substituted benzamide derivatives as potential PPARδ agonists Letters in Drug Design & Discovery, 2017, 14(11), 1239-1251.

    2017
  21. 21.

    Grewal A.S., Lather V., Pandita D., Dalal R., Anti-Inflammatory & Anti- Scopus, – 1875- Coauthor 2 . Synthesis, Docking and Anti-inflammatory Activity of Triazole Amine Derivatives as Potential Phosphodiesterase-4 Inhibitors Allergy Agents in Medicinal Chemistry, 2017, accepted.

    2017
  22. 22.

    Grewal A. S., Sharma S.K, Pandita D., Lather V., Synthesis, Docking and Evaluation of Novel Pyrazole Carboxamide Derivatives as Multifunctional Anti-Alzheimer’s Agents Journal of Medicinal Chemistry and Toxicology, 2017.

    2017
  23. 23.

    Kumari P., Pandita D., Poonia N., Lather V.; Nanomaterials in Cosmetics: Regulatory, Quality and Safety Assessment Applied Clinical Research, Clinical Trials and Regulatory Affairs, 2017, 4(2), 99-106.

    2017
  24. 24.

    Singh R., Lather V., Pandita D., Judge V., Arumugam K. N., Grewal A. S.; Synthesis, docking and antidiabetic activity of some newer benzamide derivatives as glucokinase activators Letters in Drug Design & Discovery, 13, 2017, 14, 5, 540-553.

    2017
  25. 25.

    Madaan K., Lather V., Pandita D.; Evaluation of polyamidoamine dendrimers as potential carriers for Quercetin, a versatile flavonoid Drug Delivery, 2016 Jan, 23(1), 254-62.

    2016
  26. 26.

    Poonia N., Kharb R., Lather V., Pandita D.; Nanostructured lipid carriers: versatile oral delivery vehicle Future Science OA, 2016, 2(3): FSO135.

    2016
  27. 27.

    Lather V., Sharma D., Pandita D.; Proniosomal gel mediated transdermal delivery of bromocriptine: in vitro and ex vivo evaluation Journal of Experimental Nanoscience, 2016, 11(13), 1044-1057.

    2016
  28. 28.

    Girdhar S., Pandita D., Girdhar A., Lather V.; Safety, quality and regulatory aspects of nutraceuticals. Applied Clinical Research,. Clinical Trials and Regulatory Affairs, 2017, 4(1), 36 – 42.

    2017
  29. 29.

    Kumar S., Lather V., Pandita D.; A facile green approach to prepare core-shell hybrid PLGA nanoparticles for resveratrol delivery International Journal of Biological Macromolecules, 2016, 84, 380-384.

    2016
  30. 30.

    Kumar S., Lather V., Pandita D.; Stability indicating simplified HPLC method for simultaneous analysis of resveratrol and quercetin in nanoparticles and human plasma Food Chemistry, 2016, 197, 959-964.

    2016
  31. 31.

    Grewal A. S., Pandita D., Bhardwaj S., Lather V., Recent updates on development of drug molecules for human African trypanosomiasis Current Topics in Medicinal Chemistry, 2016, 16(20), 2245-2265.

    2016
  32. 32.

    Grewal A. S., Beniwal M., Pandita D., Sekhon B. S., Lather V.; Recent Updates on Peroxisome Proliferator-Activated Receptor δ Agonists for the Treatment of Metabolic Syndrome Medicinal Chemistry, 2016, 12(1),3-21.

    2016
  33. 33.

    Grewal A. S., Lather V., Bhardwaj S., Pandita D.; Regulatory overview of biosimilars: current scenario and future opportunities Applied Clinical Research, Clinical Trials and Regulatory Affairs, 2015, 2(3), 158-164.

    2015
  34. 34.

    Girdhar S., Girdhar A., Verma S. K., Lather V., Pandita D.; Plant derived alkaloids in major neurodegenerative diseases: from animal models to clinical trials Journal of Ayurvedic and Herbal Medicine, 2015, 1(3), 91-100.

    2015
  35. 35.

    Pareek R., Verma S., Lather V., Pandita D.; Co-polymerized gellan gum: a carrier for controlled drug delivery Drug Delivery Letters; 2015, 5(3), 151-162.

    2015
  36. 36.

    Kumari S., Pandita D., Poonia N., Lather V.; Nanostructured lipid carriers for topical delivery of an anti-acne drug: characterization and ex vivo evaluation Pharmaceutical Nanotechnology, 2015, 3(2), 122-133.

    2015
  37. 37.

    Kumar S., Sangwan P., Lather V., Pandita D.; Biocompatible PLGA-oil hybrid nanoparticles for high loading and controlled delivery of resveratrol Journal of Drug Delivery Science and Technology, 2015, 30, 54-62.

    2015
  38. 38.

    Grewal A. S., Bhardwaj S., Pandita D., Lather V., Sekhon B. S.; Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases Mini-Reviews in Medicinal Chemistry, 2015, 16(2), 120- 162.

    2015
  39. 39.

    Kumar S., Lather V., Pandita D.; Green synthesis of therapeutic nanoparticles: an expanding horizon Nanomedicine, 2015, 10(15), 2451-2471.

    2015
  40. 40.

    Chopra M., Rathore N. S., Kumar S., Kumer B., Pandita D., Manuja A.; World Journal of Pharmacy and Pharmaceutical Sciences World Journal of Pharmacy and Pharmaceutical Sciences, 2015, 8, 666-673.

    2015
  41. 41.

    Pandita D., Kumar S., Lather V.; Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospective Drug Discovery Today, 2015, 20 (1) 95-104.

    2015
  42. 42.

    Pandita D., Kumar S., Poonia N., Lather V.; Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol Food Research International, 2014, 62, 1165-1174.

    2014
  43. 43.

    Madaan K., Kumar S., Poonia N., Lather V., Pandita D.; Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues Journal of Pharmacy And Bioallied Sciences, 2014, 6 (3) 139-150.

    2014
  44. 44.

    3 1 Lal R., Marwaha R. K., Pandita D., Dureja H.; Formulation and Optimization of 5- Fluorouracil Loaded Chitosan Nanoparticles Employing Central Composite Design. Drug Delivery Letters, 2012, 2(4), 281-289.

    2012
  45. 45.

    Pandita D., Santos J.L., Rodrigues J., Pêgo A.P., Granja P.L., Balian G., Tomás H.; Gene delivery into Mesenchymal Stem Cells: A biomimetic approach using RGD nanoclusters based on poly(amidoamine) dendrimers Biomacromolecules, 2011, 12 (2), 472-481.

    2011
  46. 46.

    Pandita D., Ahuja A., Lather V., Benjamin B., Dutta T., Velpandian T., Khar R.K Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel AAPS PharmSciTech, 2011, 12(2), 712-722.

    2011
  47. 47.

    Pandita D., Ahuja A., Velpandian T., Lather V., Dutta T., Khar R.K.; Development, characterization and in vitro assessment of stearylamine-based lipid nanoparticles of paclitaxel Die Pharmazie, 2011, 66, 1-7.

    2011
  48. 48.

    Santos J.L., Pandita D., Rodrigues J, Pêgo AP, Granja PL, Tomás H. Non-viral gene delivery to mesenchymal stem cells: Methods, strategies and application in bone tissue engineering and regeneration Current Gene Therapy, 2011, 11(1), 46-57.

    2011
  49. 49.

    Santos J.L., Pandita D., Rodrigues J., Pêgo A.P., Granja P.L., Balian G., Tomás H.; Receptor-Mediated Gene Delivery using PAMAM Dendrimers Conjugated with Peptides Recognized by Mesenchymal Stem Cells Molecular Pharmaceutics, 2010, 7(3), 763-774.

    2010
  50. 50.

    Santos J.L., Oliveira H., Pandita D., Rodrigues J., Pêgo A.P., Granja P.L., Tomás H.; Functionalization of Poly(amidoamine) Dendrimers with Hydrophobic Chains for Improved Gene Delivery in Mesenchymal Stem Cells Journal of Controlled Release, 2010, 144 (1), 55-64.

    2010
  51. 51.

    Pandita D., Ahuja A., Velpandian T., Lather V., Dutta T., Khar R.K.; Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique Die Pharmazie, 2009, 64(5), 301-310.

    2009
  52. 52.

    Dutta T., Garg M., Dubey V., Mishra D., Singh K., Pandita D., Singh A.K., Ravi A. K., Velpandian T., Jain N.K.; Toxicological investigation of surface engineered fifth generation poly (propyleneimine) dendrimers in vivo Nanotoxicology, 2, 62-70, 2008.

    2008
  53. 53.

    Pandita D., Alka Ahuja, T. Velpandian, Roop K. Khar.; Development and evaluation of Paclitaxel loaded solid lipid nanospheres (SLN) Indian Journal of Pharmacology, 2006, 38 (1) 87-88.

    2006
  54. 54.

    Roop K. Khar, Pandita D.; Biopharmaceutical classification system and its importance The Indian Pharmacist, 2005, 4 (41) 25-30 .

    2005
  55. 55.

    Pandita D., Dureja H., Kumar V. Lather V., An introduction to Combinatorial Chemistry- A rapid approach to lead development. pharmainfo.net,30/03/2005 .

    2005
  56. 56.

    Pandita D., Shirwaikar A.; An update on the Global Programme for Vaccine and Immunization Indian Journal of Pharmaceutical Sciences, 2004, 66 (1), 1-10.

    2004
  57. 57.

    Gupta S. K., Madaan R., Pandita D., Khan S. A.; Phytochemical and Pharmacological Investigations on Cassia fistula Linn. Journal of Science and Pharmacy, 2003, 4 (2) 57-60.

    2003
  58. 58.

    Book publications

  59. 59.

    Lather V., Poonia N., Pandita D., Mesoporous silica nanoparticles- A multifunctional nanocarrier for therapeutic applications Multifunctional Nanocarriers for Contemporary Healthcare Applications, IGI Global, 2017 .

    2017
  60. 60.

    Pandita D., Munjal A., Godara S., Lather V., Nanocarriers in drug and gene delivery Advances in Animal Biotechnology and its Applications, Springer Publishers, 2017.

    2017
  61. 61.

    Pandita D., Kumar S., Lather V., Dureja H., Nanoparticles in Anticancer Drug Delivery Encyclopedia of Nanoscience and Nanotechnology (25-Volume set), H. S. Nalwa, American Scientific Publishers, 2016, U.S.A.

    2016
  62. 62.

    Pandita D., Poonia N., Lather V., Mesoporous Silica Nanoparticles in Drug Delivery and Targeting NanoBioMedicine Vol. 1 NanoMedicine, Bhupinder Singh, Studium Press LLC, U.S.A., 2015, 267-336 ISBN: 1- 62699- 051-4.

    2015
  63. 63.

    Pandita D., Lather V., SilicaBased Nanoparticles for Theranostic Applications NanoBioMedicine, Vol. 3, NanoTheranostics, Bhupinder Singh, Studium Press LLC, U.S.A., 2015, 383-422 ISBN: 1- 62699- 053-0

    2015
  64. 64.

    Pandita D., Lather V., Nanotechnology: Novel Prospects and Perspectives Nanotechnology: Novel Prospects and Perspectives, Bhupinder Singh, Anupama Kaushik, S. K. Mehta, S. K. Tripathi, McGraw Hill Education Pvt. Ltd., 2015, 78- 84.

    2015

Awards & Achievements

  • Best Pharmaceutical Scientist Award- 2014,

    2014

  • Haryana State Branch, APTI

  • Postdoc Fellowship, FCT, Portugal, 2008-2010

    2008

  • Principal Investigator, Young Scientist Scheme, SERB, DST, 2012-15, Grant received

    2012

  • Principal Investigator, Research Promotion Scheme, AICTE, 2012-14, Grant received

    2012

  • Faculty Development Programme Grant, AICTE, Grant received (Rs. 7.00 Lacs)

  • DST Travel Grant for PharmaTech, 2012, Malaysia

    2012

  • ICMR Travel Grant for PharmaTech 2014, Bangkok h. DST Travel Grant for Controlled Release Society 2017, Boston, USA (Not...

    2014

    ICMR Travel Grant for PharmaTech 2014, Bangkok h. DST Travel Grant for Controlled Release Society 2017, Boston, USA (Not availed).

  • DST, Haryana Grant for IPR Workshop/Seminar, 2017-18, Grant received

    2017

  • Best Paper Award, 2006, 58th Indian Pharmaceutical Congress, Mumbai, India

    2006

  • Senior Research Fellowship Award, 2005, Indian Council of Medical Research, India

    2005

  • Rank Holder, M. Pharm, Manipal University, Manipal

  • Rank Holder, B. Pharm, Mysore University, Mysore

Invited Lectures & Speaker Roles

  • Best Pharmaceutical Scientist Award- 2014,

    2014

  • Haryana State Branch, APTI

  • Postdoc Fellowship, FCT, Portugal, 2008-2010

    2008

  • Principal Investigator, Young Scientist Scheme, SERB, DST, 2012-15, Grant received

    2012

  • Principal Investigator, Research Promotion Scheme, AICTE, 2012-14, Grant received

    2012

  • Faculty Development Programme Grant, AICTE, Grant received (Rs. 7.00 Lacs)

  • DST Travel Grant for PharmaTech, 2012, Malaysia

    2012

  • ICMR Travel Grant for PharmaTech 2014, Bangkok h. DST Travel Grant for Controlled Release Society 2017, Boston, USA (Not availed).

    2014

  • DST, Haryana Grant for IPR Workshop/Seminar, 2017-18, Grant received

    2017

  • Best Paper Award, 2006, 58th Indian Pharmaceutical Congress, Mumbai, India

    2006

  • Senior Research Fellowship Award, 2005, Indian Council of Medical Research, India

    2005

  • Rank Holder, M. Pharm, Manipal University, Manipal

  • Rank Holder, B. Pharm, Mysore University, Mysore

Book Chapters

  1. 1.

    Mesoporous silica nanoparticles - A multifunctional nanocarrier for therapeutic applications

    IGI Global2017
  2. 2.

    Nanocarriers in drug and gene delivery

    Springer Publishers2017
  3. 3.

    Nanoparticles in Anticancer Drug Delivery — Encyclopedia of Nanoscience and Nanotechnology

    American Scientific Publishers2016
  4. 4.

    Mesoporous Silica Nanoparticles in Drug Delivery and Targeting — NanoBioMedicine Vol. 1

    Studium Press LLC2015
  5. 5.

    Silica-Based Nanoparticles for Theranostic Applications — NanoBioMedicine Vol. 3

    2015